Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Xenter, Inc. raises $58.25 million in Series B financing to accelerate the commercial launch of its TechMed platform. This funding will also support innovation in wireless medical devices and technologies.
PRIVATEJul 16, 2026•24 days ago
Amount Raised
$58.3 Million
Round Type
Series B
Description
Xenter, Inc., a leader in healthcare intelligence, successfully closed its Series B financing on June 30th, raising a total of $58.25 million. The round included existing shareholders and prominent healthcare investors. The funds will be used for commercial launch, technology development, and regulatory initiatives for Xenter's TechMed platform. This financing underlines the growing interest in Xenter's capabilities in capturing and utilizing healthcare data.
Related People
Suggested for you
3 contactsVerified contactsBen, Vice President Marketing hidden hidden hidden
Funding Insights
Based on industry dataTimeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech